Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

233 results

Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Clinical Application of Droplet Digital PCR for Hepatitis Delta Virus Quantification.
Olivero A, Rosso C, Ciancio A, Abate ML, Nicolosi A, Troshina G, Armandi A, Ribaldone DG, Saracco GM, Bugianesi E, Rizzetto M, Caviglia GP. Olivero A, et al. Among authors: ciancio a. Biomedicines. 2022 Mar 29;10(4):792. doi: 10.3390/biomedicines10040792. Biomedicines. 2022. PMID: 35453541 Free PMC article.
Treatment with interferon-alpha2b of naive non-cirrhotic patients with chronic hepatitis C according to viraemia and genotype. Results of a randomized multicentre study. The North West Italian Hepatological Group.
Saracco G, Ciancio A, Ghisetti V, Rocca G, Cariti G, Andreoni M, Tabone M, Roffi L, Calleri G, Ballaré M, Terreni N, Sartori M, Tappero GF, Traverso A, Poggio A, Orani A, Maggi G, Di Napoli A, Arrigoni A, Rizzetto M; North West Italian Hepatological Group. Saracco G, et al. Among authors: ciancio a. Eur J Gastroenterol Hepatol. 2001 Feb;13(2):149-55. doi: 10.1097/00042737-200102000-00010. Eur J Gastroenterol Hepatol. 2001. PMID: 11246614 Clinical Trial.
A randomized 4-arm multicenter study of interferon alfa-2b plus ribavirin in the treatment of patients with chronic hepatitis C not responding to interferon alone.
Saracco G, Ciancio A, Olivero A, Smedile A, Roffi L, Croce G, Colletta C, Cariti G, Andreoni M, Biglino A, Calleri G, Maggi G, Tappero GF, Orsi PG, Terreni N, Macor A, Di Napoli A, Rinaldi E, Ciccone G, Rizzetto M. Saracco G, et al. Among authors: ciancio a. Hepatology. 2001 Jul;34(1):133-8. doi: 10.1053/jhep.2001.25636. Hepatology. 2001. PMID: 11431744 Clinical Trial.
A randomized 4-arm multicenter study of interferon alfa-2b plus ribavirin in the treatment of patients with chronic hepatitis C relapsing after interferon monotherapy.
Saracco G, Olivero A, Ciancio A, Carenzi S, Smedile A, Cariti G, Andreoni M, Orsi PG, Biglino A, Tabone M, Roffi L, Croce G, Manca A, Tappero G, Ciccone G, Rizzetto M. Saracco G, et al. Among authors: ciancio a. Hepatology. 2002 Oct;36(4 Pt 1):959-66. doi: 10.1053/jhep.2002.35442. Hepatology. 2002. PMID: 12297844 Clinical Trial.
Therapy of chronic hepatitis C: a critical review.
Saracco G, Olivero A, Ciancio A, Carenzi S, Rizzetto M. Saracco G, et al. Among authors: ciancio a. Curr Drug Targets Infect Disord. 2003 Mar;3(1):25-32. doi: 10.2174/1568005033342127. Curr Drug Targets Infect Disord. 2003. PMID: 12570730 Review.
Digestive endoscopy is not a major risk factor for transmitting hepatitis C virus.
Ciancio A, Manzini P, Castagno F, D'Antico S, Reynaudo P, Coucourde L, Ciccone G, Del Piano M, Ballarè M, Peyre S, Rizzi R, Barletti C, Bruno M, Caronna S, Carucci P, Venon Wde B, De Angelis C, Morgando A, Musso A, Repici A, Rizzetto M, Saracco G. Ciancio A, et al. Ann Intern Med. 2005 Jun 7;142(11):903-9. doi: 10.7326/0003-4819-142-11-200506070-00008. Ann Intern Med. 2005. PMID: 15941697
233 results